Building digital health products that scale—why chief medical and scientific officers are the key to widespread adoption
Date: Tuesday, August 24, 2021
Time: 11:00AM – 12:00PM PST
Chief Medical Officers and Chief Scientific Officers are critical first hires for a digital health company. From accelerating your product’s path to market to ensuring your claims are bound by science and balancing consumer needs with medical integrity, CMOs and CSOs can be a founding team’s lifeboat.
In this webinar, we’ll cover:
- A day in the life of a CMO or CSO in a digital health company
- How CMOs and CSOs with varying backgrounds can play important roles in your business
- The clash between the commercial mindset and medical responsibility
- What happens when you don’t have a CMO or CSO from the start
Meet the Panelists
Chet Robson DO, MHCDS, FAAFP (Moderator)
Chief Clinical Officer, Walgreens
Dr. Robson provides evidence-based leadership for pharmacy, specialty pharmacy, healthcare services, digital innovation and retail merchandising. He is the medical director of the Walgreens Pandemic Response and is leading the development of a healthcare destination that integrates primary care, pharmacy, and ancillary services (labs and digital resources) into the flow of people’s lives. He also leads Walgreens’ development of pharmacogenomics and clinical research. Dr. Robson holds an MBA in healthcare delivery science from Dartmouth.
Federico Monzon, MD
Strategy Consultant, Medical Genomics
Dr. Monzon is a molecular pathologist with expertise in clinical genomics, molecular diagnostics and pathology informatics. He was chief medical officer (CMO) at Castle Biosciences and is currently CMO at Universal Diagnostics. He has a strong track record of clinical lab innovation focused on translating novel genomic technologies into medicine. At the University of Pittsburgh, he led the clinical validation study supporting FDA clearance of one of the first gene expression tests using gene expression microarrays (Pathwork Tissue of Origin). Dr. Monzon has directed molecular diagnostics laboratories at Houston Methodist Hospital and at Baylor College of Medicine (BCM), where he oversaw the launch of the first NGS-based clinical cancer exome in the US. At Invitae, he led the oncology team, working closely with the commercial team on business strategy and medical affairs in Latin America.
Madhuri Hegde, PhD, DABMG, FACMG
SVP and Chief Scientific Officer, Global Lab Services at PerkinElmer, Inc.
Bernard Esquivel, MD, PhD
Precision Medicine Advocate & Executive Leader
Dr. Esquivel is a practicing physician-scientist, senior executive, and international business leader with expertise in developing new markets in genomics and precision medicine. As founder and president of ALAMP, he mobilized the regional healthcare community to engage in precision medicine. ALAMP now includes >400 members from nine Latin American countries and holds symposia, provider workshops, and other educational events.